8th Neurodegenerative Drug Development Summit
Previously the World CNS Summit, the Neurodegenerative Drug Development Summit returns to Boston to host over 150 neurodegeneration experts to enable them to overcome their translational challenges and successfully translate into the clinic.
Across 34 case-study-driven scientific presentations, 5 interactive workshops and 2 parallel tracks of learning, this meeting will deep-dive into the translational challenges faced by drug developers in this established industry and examine advances in new biomarker technologies, the potential of gene therapy, emerging targets and more.
Leading organizations at the cutting edge of the field, including Biogen, AbbVie, Sanofi and more, are attending this meeting to share their progress and network for future collaborations. Don’t miss this opportunity immerse yourself in the neurodegenerative community to help refresh the neurodegenerative approach and challenge traditional thinking to advance clinical progress.